Clinical Trials Browser

Prostatic Neoplasms × perflutren × 90 days × Clear all

NCT06024772 2026-06-05

Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer

Phase 3 Not yet recruiting

Prostatic Neoplasms